AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

2025 Avoca Industry Survey

The survey is closed — thank you for participating!


 
Avoca, a WCG company, is dedicated to increasing quality, improving efficiency, and ensuring compliance in the clinical trial execution process. For more than 20 years, Avoca has surveyed the industry to gain an understanding of key trends affecting clinical development. This year’s survey aims to understand opinions and experiences as it relates to the final ICH E6 (R3) guidance.

A report of aggregate findings will be available in June 2025 under Avoca’s Research Reports library and will offer a comprehensive overview of how finalized ICH E6 (R3) guidelines are being received and implemented across the industry.

 

 

RELATED CONTENT:

WCG’s Avoca Quality Consortium (AQC) can support successful implementation of ICH E6 (R3) with resources including side-by-side comparison tools and recent webinars to enable continuous quality compliance.
Learn more ››

This website uses cookies to improve functionality and performance. If you continue browsing the site, you are giving implied consent to the use of cookies on this website. See our Privacy Policy for details.

I Accept